Diabetes drug shows promise against deadly skin cancer in early trial
NCT ID NCT01840007
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested whether metformin, a common diabetes drug, could help treat advanced melanoma that had spread and stopped responding to other treatments. Twenty adults with stage IIIC or IV melanoma took metformin to see if it could shrink their tumors. The goal was to find a new, safer option for a cancer with very few effective treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA (STAGE IIIC NON-RÉSÉCABLE OR NO SURGICALLY CURABLE OR STAGE IV WITH CLASSIFICATION AJCC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bahadoran
Nice, Alpes-Maritimes, 06200, France
-
MORTIER Laurent
Lille, Nord, 59000, France